Metoprolol Succinate Tablet, Film Coated, Extended Release
Product Images NDC 72603-142

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72603-142). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container25mg100 (Container25mg100)

Label for Metoprolol Succinate Extended-Release Tablets USP, 25 mg strength. The label indicates 100 film-coated extended-release tablets. It shows the NDC 72603-142-01 and is labeled for Rx only. Manufactured by Dr. Reddy's Laboratories Limited, India, and labeled for Northstar Rx LLC, Memphis, TN. Storage instructions and warnings about keeping out of children's reach are included.*

FDA Label Image

Container25mg500 (Container25mg500)

Metoprolol succinate extended-release tablets, USP 25 mg strength. The label indicates a package of 500 film-coated oral tablets. It is manufactured by Dr. Reddy's Laboratories Limited in India for Northstar Rx LLC, Memphis, TN. Includes storage instructions and a barcode.*

FDA Label Image

Container50mg100 (Container50mg100)

Label for Metoprolol Succinate Extended-Release Tablets, USP 50 mg, film-coated, oral tablets. The label states the package contains 100 tablets and is manufactured for Northstar Rx LLC, Memphis, TN, with manufacturing by Dr. Reddy's Laboratories Limited, India. The label includes storage instructions, usage warning, and a barcode.*

FDA Label Image

Container50mg500 (Container50mg500)

Label for Metoprolol Succinate extended-release tablets USP, 50 mg strength, film-coated with a package size of 500 tablets. Manufactured by Dr. Reddy's Laboratories Limited for Northstar Rx LLC. Includes storage instructions and a barcode on the right side.*

FDA Label Image

Figure (Figure)

A forest plot titled "Results for Subgroups in MERIT-HF," showing relative risk and 95% confidence intervals for three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include demographics, clinical conditions, and heart-related measures, comparing metoprolol succinate extended-release tablets against placebo.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol succinate, depicting the molecular arrangement including phenyl group, ether and hydroxyl functional groups, and the succinate moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.